Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
Open Access
- 9 December 2022
- journal article
- research article
- Published by Elsevier in Diabetes Epidemiology and Management
- Vol. 10, 100123
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerationsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- New Guidance on Managing Inpatient Hyperglycaemia during the COVID‐19 PandemicDiabetic Medicine, 2020
- Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United StatesJournal of Diabetes Science and Technology, 2020
- Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 PandemicJournal of Diabetes Science and Technology, 2020
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)Clinical Infectious Diseases, 2020
- Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative reviewWorld Journal of Diabetes, 2015
- The high incidence of steroid-induced hyperglycaemia in hospitalDiabetes Research and Clinical Practice, 2013
- Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPDThe Journal of Clinical Endocrinology & Metabolism, 2011
- Prevalence and Predictors of Corticosteroid-Related Hyperglycemia in Hospitalized PatientsEndocrine Practice, 2006
- Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2002